NCT06492746View on ClinicalTrials.gov

Personal BP - CAI Study

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 3, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Blood Pressure
Interventions
DEVICE

HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring

The arterial line with Acumen IQ sensor and Foresight Elite sensor will be connected to the HemoSphere monitor with laptop displaying the CAI parameter.

Trial Locations (1)

60611

RECRUITING

Northwestern University Hospital, Evanston

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY